MX2022012735A - Agente para mejorar la calidad del sueño. - Google Patents
Agente para mejorar la calidad del sueño.Info
- Publication number
- MX2022012735A MX2022012735A MX2022012735A MX2022012735A MX2022012735A MX 2022012735 A MX2022012735 A MX 2022012735A MX 2022012735 A MX2022012735 A MX 2022012735A MX 2022012735 A MX2022012735 A MX 2022012735A MX 2022012735 A MX2022012735 A MX 2022012735A
- Authority
- MX
- Mexico
- Prior art keywords
- sleep
- agent
- improving quality
- improving
- quality
- Prior art date
Links
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 3
- 230000037406 food intake Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
- A23L29/035—Organic compounds containing oxygen as heteroatom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/31—Foods, ingredients or supplements having a functional effect on health having an effect on comfort perception and well-being
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/032—Citric acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
Abstract
Se proporciona una composición farmacéutica útil que presenta efectos de mejora de la calidad del sueño, alivio del estrés y reducción de la sensación de fatiga en un blanco mamífero (por ejemplo, un ser humano) mediante la ingestión o administración de una composición que contiene al menos una sustancia seleccionada del grupo que consta de ácido cítrico y una de sus sales.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020072192 | 2020-04-14 | ||
JP2020123385 | 2020-07-20 | ||
PCT/JP2021/015273 WO2021210565A1 (ja) | 2020-04-14 | 2021-04-13 | 睡眠の質の改善剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022012735A true MX2022012735A (es) | 2022-11-07 |
Family
ID=78084866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022012735A MX2022012735A (es) | 2020-04-14 | 2021-04-13 | Agente para mejorar la calidad del sueño. |
Country Status (11)
Country | Link |
---|---|
US (1) | US20230149330A1 (es) |
EP (1) | EP4137206A4 (es) |
JP (1) | JPWO2021210565A1 (es) |
KR (1) | KR20230005819A (es) |
CN (1) | CN115397262A (es) |
AU (1) | AU2021257176A1 (es) |
BR (1) | BR112022020334A2 (es) |
CA (1) | CA3175207A1 (es) |
IL (1) | IL297227A (es) |
MX (1) | MX2022012735A (es) |
WO (1) | WO2021210565A1 (es) |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4913410B1 (es) | 1970-05-29 | 1974-03-30 | ||
CN1172645A (zh) * | 1997-07-18 | 1998-02-11 | 杨巍 | 柠檬酸盐溶石液及其制备方法 |
KR100379596B1 (ko) * | 1999-09-13 | 2003-04-10 | 주식회사 한국팜비오 | 구연산칼륨을 주제로 한 요로결석치료제의 제조방법 |
JP3907964B2 (ja) * | 2001-04-25 | 2007-04-18 | 株式会社 伊藤園 | 精神疲労軽減組成物、集中力維持増強組成物及び精神的活力維持増強組成物 |
CN1780562B (zh) | 2004-01-14 | 2011-04-13 | 味之素株式会社 | 含甘氨酸食品及其应用 |
ATE477809T1 (de) * | 2004-04-06 | 2010-09-15 | Taiyokagaku Co Ltd | Verwendung einer kombination von theanin und serotonin gegen schlafstörung |
JP2007230954A (ja) * | 2006-03-02 | 2007-09-13 | Fancl Corp | 睡眠誘導剤及びストレス性不眠症改善剤 |
JP2009023948A (ja) * | 2007-07-19 | 2009-02-05 | Pokka Corp | ドーパミン抑制剤 |
JP5282202B2 (ja) * | 2008-04-11 | 2013-09-04 | 成都金麒麟生物健康科技有限公司 | 抗ストレス剤または睡眠改善剤 |
WO2009143356A1 (en) * | 2008-05-21 | 2009-11-26 | Ferring International Center S.A. | Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia |
JP2014172892A (ja) * | 2013-03-12 | 2014-09-22 | Fujifilm Corp | 睡眠改善剤、ノンレム睡眠時間増加剤及び鎮静剤 |
CN105209120A (zh) * | 2013-03-15 | 2015-12-30 | 纽约大学 | 含有柠檬酸盐的饮料 |
JP6976515B2 (ja) | 2017-07-21 | 2021-12-08 | 国立大学法人 筑波大学 | 睡眠改善剤 |
JP7231898B2 (ja) | 2018-09-26 | 2023-03-02 | ビーエイチエヌ株式会社 | 睡眠の質改善剤 |
EP3868215A4 (en) * | 2018-10-16 | 2022-07-27 | Nippon Chemiphar Co., Ltd. | MEANS OF IMPROVING SLEEP QUALITY |
EP3868370A4 (en) * | 2018-10-17 | 2022-06-29 | Nippon Chemiphar Co., Ltd. | Therapeutic or prophylactic agent for nocturia |
JP7192399B2 (ja) | 2018-10-31 | 2022-12-20 | Tdk株式会社 | 薄膜キャパシタ |
JP6815547B2 (ja) | 2020-04-21 | 2021-01-20 | 株式会社フジタ | 床振動解析プログラムおよび床振動解析装置 |
-
2021
- 2021-04-13 CA CA3175207A patent/CA3175207A1/en active Pending
- 2021-04-13 JP JP2022515390A patent/JPWO2021210565A1/ja active Pending
- 2021-04-13 AU AU2021257176A patent/AU2021257176A1/en active Pending
- 2021-04-13 WO PCT/JP2021/015273 patent/WO2021210565A1/ja unknown
- 2021-04-13 IL IL297227A patent/IL297227A/en unknown
- 2021-04-13 BR BR112022020334A patent/BR112022020334A2/pt unknown
- 2021-04-13 CN CN202180028046.2A patent/CN115397262A/zh active Pending
- 2021-04-13 MX MX2022012735A patent/MX2022012735A/es unknown
- 2021-04-13 KR KR1020227034721A patent/KR20230005819A/ko active Search and Examination
- 2021-04-13 EP EP21788851.0A patent/EP4137206A4/en active Pending
- 2021-04-13 US US17/995,333 patent/US20230149330A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
IL297227A (en) | 2022-12-01 |
BR112022020334A2 (pt) | 2022-11-22 |
CA3175207A1 (en) | 2021-10-21 |
EP4137206A1 (en) | 2023-02-22 |
JPWO2021210565A1 (es) | 2021-10-21 |
US20230149330A1 (en) | 2023-05-18 |
AU2021257176A1 (en) | 2022-11-10 |
EP4137206A4 (en) | 2024-05-22 |
WO2021210565A1 (ja) | 2021-10-21 |
KR20230005819A (ko) | 2023-01-10 |
CN115397262A (zh) | 2022-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Allen et al. | Selenium sulfide: adjunctive therapy for tinea capitis | |
Sher et al. | Acute myopathy with selective lysis of myosin filaments | |
RS53814B1 (en) | EXENDIN FOR THE TREATMENT OF Diabetes mellitus and weight loss | |
WO2007057748A2 (en) | Use of colostrum for the prophylaxis of influenza syndromes | |
JP2011116690A (ja) | 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物 | |
JP2001122774A (ja) | 眼科用組成物及びソフトコンタクトレンズへの吸着抑制方法 | |
MX2022012735A (es) | Agente para mejorar la calidad del sueño. | |
JP2001192333A (ja) | コンタクトレンズ用眼科用組成物 | |
JP2011098961A (ja) | 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物 | |
Bloomfield et al. | Cocoa flavanols protect cognitive function, cerebral oxygenation, and mental fatigue during severe hypoxia | |
Toronto Aerosolized Pentamidine Study (TAPS) Group | Acute pulmonary effects of aerosolized pentamidine: a randomized controlled study | |
JP2003073303A (ja) | 眼局所用液剤の清涼化作用の持続方法 | |
MX2023010545A (es) | Inhibidores de integrinas alfa v beta 6 y alfa v beta 1 y usos de los mismos. | |
JP2017071600A (ja) | くすぶり炎症抑制剤 | |
US20150366971A1 (en) | Vitamin preparation | |
KR100880537B1 (ko) | 칸탈로프 멜론추출물과 글리아딘 결합물을 유효성분으로 하는 기억, 집중력, 학습능력 개선제 | |
Ferrer et al. | A nasal spray solution of grapefruit seed extract plus Xylitol displays virucidal activity against SARS-Cov-2 in vitro | |
US6270756B1 (en) | Weight loss induced by alpha interferon and gamma interferon | |
Sagdullayevna et al. | HYPOMENSTRUAL SYNDROME IN ADOLESCENT GIRLS IN THE CONTEXT OF THE COVID-19 PANDEMIC | |
US20100216876A1 (en) | Antidiarrhetic composition, product containing the same and method of preventing diahhrea | |
Ciświcka-Sznajderman et al. | The effect of combined treatment with phenformin and stanazolol on blood lipids and fibrinolytic activity in patients with hypertriglyceridaemia | |
TWI816813B (zh) | 水性組成物、添加回收率改善方法、添加回收試驗方法 | |
Gea Guiral et al. | Respiratory muscle senescence in ageing and chronic lung diseases | |
Du Puy | Simon P. Mooijaart, MD, PhD | |
Hirschman et al. | The effect of proteolytic enzymes and hyaluronidase in vitro on the calcification mechanism of epiphyseal cartilage |